CTOR

Citius Oncology, Inc. Common Stock
CTOR

Overview Fund Activity

22 hedge funds and large institutions have $56.8M invested in Citius Oncology, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
22
Holders Change
-2
Holders Change %
-8.33%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
6
Reduced
5
Closed
5
Calls
–
Puts
$2.93M
Net Calls
-$2.93M
Net Calls Change
-$2.93M

Top Buyers

1
RCM
1
Rivernorth Capital Management
Florida
$3.68M
2
KL
2
KIM LLC
Kansas
$3.42M
3
MSU
3
Mizuho Securities USA
New York
$4.59M
4
Bank of Montreal
4
Bank of Montreal
Ontario, Canada
$774K
5
VF
5
Virtu Financial
New York
$447K

Top Sellers

1
WAM
1
Weiss Asset Management
Massachusetts
$0
2
SCM
2
Shaolin Capital Management
Florida
$0
3
RCM
3
Radcliffe Capital Management
Pennsylvania
$2.39M
4
SG
4
StoneX Group
New York
$0
5
SSA
5
Schonfeld Strategic Advisors
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
SSA
26
Schonfeld Strategic Advisors
New York
– -$131K -12,600 Closed
UBS Group
27
UBS Group
Switzerland
– -$15.6K -1,504 Closed
1
2